Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Treating Hearing Loss to Improve Mood and Cognition in Older Adults
Treating Hearing Loss to Improve Depression in Older Adults
Sponsor:National Institute on Aging
Enrolling:Male and Female Patients
Study Length:12 Weeks
Clinic Visits:6
Minimum Age:60 years old
IRB Number:7540
U.S. Government ID:NCT03321006
Contact: Marika Chrisanthopoulos: 646-774-8677 / marika.chrisanthopoulos@nyspi.columbia.edu
Additional Study Information:

In this research study, you will be fitted with hearing aids that may be fully tuned to improve your hearing (full dose) or may be only partially tuned and not likely to substantially improve your hearing (low dose). You will receive a free hearing aid that will be at full dose at the end of the 12 week study. You will also receive treatment for depression with an FDA approved medication called escitalopram (Lexapro) or duloxetine (Cymbalta). Escitalopram is a Selective Serotonin Reuptake Inhibitor (SSRI) medication, and duloxetine is a Selective Serotonin-Norepinephrine Reuptake Inhibitor (SSNRI) that both appear to help with symptoms of depression. The purpose of this study is to determine whether treating hearing loss is helpful for depression over and above the known effects of antidepressants.

This study is closed
Investigator
Bret Rutherford, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Marika Chrisanthopoulos
Email: marika.chrisanthopoulos@nyspi.columbia.edu
Phone: 646-774-8677